Your browser doesn't support javascript.
loading
The efficacy and safety of hypofractionated radiotherapy with concurrent anti-HER-2 therapy following breast-conserving therapy for breast cancer.
Dreyfuss, Alexandra D; Barsky, Andrew R; Taunk, Neil K; Clark, Amy S; Freedman, Gary M.
Afiliación
  • Dreyfuss AD; Radiation Oncology, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Barsky AR; Radiation Oncology, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Taunk NK; Radiation Oncology, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Clark AS; Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Freedman GM; Radiation Oncology, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania.
Breast J ; 25(6): 1097-1103, 2019 11.
Article en En | MEDLINE | ID: mdl-31254304

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Carcinoma Ductal de Mama / Hipofraccionamiento de la Dosis de Radiación Tipo de estudio: Observational_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Breast J Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Carcinoma Ductal de Mama / Hipofraccionamiento de la Dosis de Radiación Tipo de estudio: Observational_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Breast J Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article